This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Rocket Stocks to Buy This Week

BALTIMORE ( Stockpickr) -- And just like that, the "fiscal cliff" has replaced the election as the most newsworthy tidbit on Wall Street. I hope you're ready to hear a lot more about it in the next month or two.

>>Trade 5 Hated Names to Beat the Market

How the fiscal cliff impacts Mr. Market still remains to be seen, but as the New Year's deadline draws near, you can bet that the drag on stocks will only get stronger. That's why it's so important for Washington to figure out a workable deal early on -- we don't want a repeat of the debt ceiling debacle that happened last year.

In the meantime, it's important to remember that the fiscal cliff isn't the only factor impacting the markets. With bargains still to be had in equities after this past quarter's correction in the S&P 500, there's at least one very good reason not to hate stocks as we approach 2013. That's especially true given the S&P's historical propensity for a push higher in the last couple of months of the year.

So, despite all the noise that's going on this week, we're turning to a new set of Rocket Stocks that look ready to move higher.

For the uninitiated, "Rocket Stocks" are our list of companies with short-term gain catalysts and longer-term growth potential. To find them, I run a weekly quantitative screen that seeks out stocks with a combination of analyst upgrades and positive earnings surprises to identify rising analyst expectations, a bullish signal for stocks in any market. After all, where analysts' expectations are increasing, institutional cash often follows.

In the last 176 weeks, our weekly list of five plays has outperformed the S&P 500 by 75.57%.

>>5 Dividend Stocks Set to Give Shareholders a Raise

Without further ado, here's a look at this week's Rocket Stocks.

Watson Pharmaceuticals

First up is Watson Pharmaceuticals (WPI), the world's third-largest generic drug maker. While Watson may not have the same household name sported by conventional big pharma stocks, investors shouldn't ignore this firm right now -- especially as patent drop-offs plague conventional drug makers.

Watson's recently-closed deal to acquire Actavis is a game changer for the firm. It gives Watson considerable global scale, ramping up Watson's total share of the generics market to around 10%. Size matters in the generics business, and as a result, the combined firm boasts some serious advantages over smaller rivals who lack the wherewithal to pursue more complex drugs. Complexity is Watson's bread and butter -- the firm focuses on drugs that are more challenging to manufacture, generating bigger margins for its trouble.
1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
WPI $85.73 0.00%
IR $55.29 -0.79%
PPL $30.99 -1.21%
PVH $118.98 1.71%
SRCL $141.14 -0.61%

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs